FLGT Earnings Call Analysis: Revenue Loss and Acquisition Impact

Fulgent Genetics' recent earnings call has sparked market concern, with a $60M revenue loss from the VA in-housing testing. However, the company has maintained a good relationship with the VA and has replaced the lost revenue with an acquisition, expecting 9% growth overall this year. The acquisition adds 20-30 sales reps, all with cross-selling opportunities, and will be upgraded with digital sli

Sector: Finance | Confidence: 90%
Source: https://www.reddit.com/r/investing/comments/1rg9hiy/crazy_how_bad_market_is_treating_flgt_earnings/

---
Council (3 models): Synthesis failed

#FIRE #Circle #finance